Synthesized from 40+ experts
How to start, slowly.
Pick one goal. Start with one compound at the lowest dose. Re-test bloodwork at four weeks. Then decide.
Tailor for you · optional
Step 1
Foundation rules
Where every expert agrees, without exception.
- 01
Get bloodwork first — period.
CBC, CMP, lipid panel, HbA1c, fasting glucose, total + free testosterone, IGF-1, hs-CRP, TSH/free T4. You can't tell if a compound is helping if you don't know your baseline.
Every single expert in our corpus opens with this.
- 02
Pick ONE goal first.
Don't stack a fat-loss protocol with a longevity protocol with a cognitive protocol. You'll learn nothing about any of them and you'll multiply side-effect risk.
Bachmeyer, Tatem, Jones DC all repeat this.
- 03
Start at the lowest studied dose.
Wait 4 weeks before judging anything. Add a second compound only after the first has shown effect or clear absence of effect.
Universal across the corpus.
- 04
One change at a time.
If you start a new peptide AND a new training program AND a new diet in the same week, you'll learn nothing about any of them.
Andy Galpin and Layne Norton repeat this constantly.
- 05
Cycle on, cycle off.
Every peptide we cover has a cycle structure. Receptor habituation is real. Continuous use of compounds designed for cyclical use shortens their effective lifespan.
Bachmeyer and JD Denham emphasize this most strongly.
- 06
Talk to a real doctor.
Not a clinic that sells the thing they're prescribing. A primary care physician who will run your labs and tell you when to stop.
Universal across the corpus and the only legal-cover position we'll publish.
Step 2
Pick your goal
Each track shows the lowest-risk starter, what to add next, and the full advanced stack.
Fat Loss
Lose body fat without losing muscle.
Start here · lowest risk
Tirzepatide
Most-studied GLP-1/GIP dual agonist. Start at 0.5 mg, titrate up every 4 weeks. The lowest-risk entry point — strong human safety data, side effects are predictable.
Then add
Retatrutide
When: Once you've held a maintenance dose of Tirzepatide for 8+ weeks and want the glucagon-receptor edge for visceral fat. Or skip Tirz and start here under physician supervision.
Full advanced stack
| Retatrutide | 4–8 mg/week (titrated) | Weekly SubQ |
| AOD-9604 | 30 units fasted AM | Mon–Fri |
| MOTS-c | 1–10 mg | Workout days, fasted AM |
| Tesamorelin | 1 mg AM + 1 mg PM | 5 days on / 2 off — visceral fat finisher |
Expert consensus
Cycle structure
Approximate cost
What to monitor
Bloodwork: Fasting glucose + HbA1c (8–12 wks) · Lipid panel · ALT/AST · Resting HR (+8–10 bpm = back off)
Common mistakes
- ×Going keto on Retatrutide — Bachmeyer says 40–55% carbs required for the glucagon receptor
- ×Chasing the scale weekly before week 4 — judge at week 8
- ×Stacking Reta + Tirz simultaneously — Bachmeyer warns against this
Muscle & Recovery
Heal injuries, build lean mass, improve sleep depth.
Start here · lowest risk
BPC-157
Lowest-risk healing peptide. Decades of animal data, no serious adverse events in humans, clear effect on tendon/gut/inflammation. Universal expert endorsement.
Then add
TB-500
When: Add after 4 weeks on BPC-157 if you have systemic injuries (multiple sites, soft tissue) or want amplified recovery. The classic 'Wolverine stack.'
Full advanced stack
| BPC-157 | 250–500 mcg/day | SubQ daily |
| TB-500 | 2 mg every other day | SubQ |
| CJC-1295 (no-DAC) | 1 mg | Before bed, 5 on / 2 off |
| Ipamorelin | 300 mcg | Stacked with CJC, before bed |
Expert consensus
Cycle structure
Approximate cost
What to monitor
Bloodwork: IGF-1 quarterly (don't run too high) · Total + free T · CBC (hematocrit under 50%)
Common mistakes
- ×CJC with DAC instead of no-DAC — 6–8 day active version has no off switch (Dr. Jones DC)
- ×AM dosing GH peptides — pituitary repair window is overnight; dose before bed
- ×MK-677 instead of secretagogues — Dr. Tatem ran personal trial, hit pre-diabetic A1C; avoid
Longevity & Cellular Health
Mitochondrial repair, immune balance, healthspan.
Start here · lowest risk
Thymosin Alpha-1
FDA-approved (Zadaxin). Acts as an immune 'thermostat' — up-regulates when needed, calms when overactive. Cleanest-profile longevity peptide to start with.
Then add
MOTS-c
When: After 4–6 weeks on TA-1 if you want mitochondrial biogenesis. Bachmeyer: must be paired with magnesium glycinate 400 mg + CoQ10 200 mg as co-factors.
Full advanced stack
| Thymosin Alpha-1 | 0.5 mg/day | SubQ, 4–6 wk cycle |
| Epitalon | Per compounder | 10-day course, 2–3x/year |
| MOTS-c | 1–10 mg | Workout days |
| SS-31 | 0.5–2 mg/day | 8 weeks BEFORE adding MOTS-c (Bachmeyer's sequence) |
| NAD+ | 50 mg SubQ or 250–500 mg oral NMN | AM |
Expert consensus
Cycle structure
Approximate cost
What to monitor
Bloodwork: hs-CRP (target <2.0) · IGF-1 · CMP · Epigenetic age test annually
Common mistakes
- ×Adding SS-31 before MOTS-c is established — Bachmeyer: 'rebuilt engine in a car with no gas'
- ×Running MOTS-c year-round — Enhanced Man warns: fast heartbeat + insomnia at high doses
- ×Skipping magnesium glycinate + CoQ10 as MOTS-c co-factors — required, not optional
Cognitive & Focus
Sharper recall, lower anxiety, BDNF/NGF boost.
Start here · lowest risk
Semax
Russian-developed neuropeptide with strong BDNF/NGF effect. Cyclical only — 1 month on, 1 week off. Cleanest cognitive entry point with established dosing.
Then add
Selank
When: Add as PM counterpart for calm + focus balance. Jacob Nachinson's locked pairing: Semax AM, Selank PM.
Full advanced stack
| Semax | 500 mcg/day | AM SubQ, 1 mo on / 1 wk off |
| Selank | Per compounder | PM, paired with Semax |
| Methylene Blue | 5–10 mg/day | Earlier in day; 2 mo on / 1 mo off; MUST pair 500 mg Vit C |
| BPC-157 | 250–500 mcg | Daily — secondary BDNF benefit |
Expert consensus
Cycle structure
Approximate cost
What to monitor
Bloodwork: Nothing specific — watch for overstimulation (disrupted sleep, elevated HR)
Common mistakes
- ×MB with SSRIs — serotonin syndrome risk, hard contraindication
- ×Nasal Semax instead of SubQ — SubQ outperforms intranasal systemically (JD Denham)
- ×Running Semax daily without cycling — Dr. Jones DC: receptors habituate
Step 3
What experts warn against
Hard rules — these come up across multiple sources.
- ×
MK-677 (Ibutamoren)
Spikes insulin resistance and A1C. Dr. Tatem's personal trial hit pre-diabetic range. Banned from compounding 2023.
Jones DC, Froese, Tatem
- ×
CJC-1295 with DAC
6–8 day active half-life with no off-switch. The DAC version dysregulates GH pulsatility long-term.
Dr. Jones DC, Bachmeyer, JD Denham
- ×
MB with SSRIs
Methylene Blue + SSRIs = serotonin syndrome risk. Hard contraindication.
Universal
- ×
Stacking SLU-PP-332 with BAM-15
Mitochondrial damage. Castore (EliteFTS) ended up in the ICU on a similar over-stack.
Castore
- ×
Going keto on Retatrutide
Glucagon receptor effectiveness drops ~40% on low-carb. You'll get muscle catabolism instead of fat loss.
Bachmeyer
- ×
GH peptides with active cancer history
Theoretical concern across all GH-axis peptides. IGF-1 is permissive for cell replication.
Universal — flag with oncologist before any GH peptide use
Still not sure?
Tell the AI your situation — current bloodwork, what you've tried, what's not working — and it'll point you at the track that fits.
Ask the AI →